IMO. RAP will once again climb up, it will just take a little longer then last time, a new board member would be nice too.
Sleep Apnea approvals will kick start the recovery.
FDA meeting will also spin some light on the situation.
CE and TGA is still enough to kick start something.
all in all, I expect some sort of exit plan from management this year and Morgan’s will probably have something to say about that too.
Ann: Update on US FDA De Novo Classification Request, page-184
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 134 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)